Here’s my Pick of the Week’s News, from stories published on Multiple Sclerosis News Today.
Very few people living with MS or anyone close by affected by the disease can really be surprised by the findings of a new study into what is termed as “progressive dwindling.”
The study focused on one aspect of multiple sclerosis that is sometimes overlooked by researchers: the tendency over time for people with MS to become increasingly frail and dependent on caregivers, with diminished energy and heightened disability. The report, “Progressive Dwindling in Multiple Sclerosis: An Opportunity to Improve Care,” was published July 21 in the journal PloS One.
To study progressive dwindling, the researchers obtained death certificates and clinical information on 582 MS patients in the U.K., who died between January 1998 and February 2015. Led by Jessica E. Martin of the Centre for Neuroinflammation and Neurodegeneration, Division of Brain Sciences, Imperial College London, the team tried to identify how many of these people went through progressive dwindling, as well as the factors that might predict this development.
Overall, the scientists found that 73.7 percent of the study’s patients experienced progressive dwindling before dying, going through an extended, years-long decline. A total of 72.5 percent died due to complications related to their MS. These patients commonly had more aggressive forms of MS from the disease’s onset, which occurred at an earlier age and resulted in earlier “symptom onset, progression, wheelchair use, and death,” the researchers said.
I really hope that this research has some practical use because the findings come as no surprise and, with the exception of exact percentages, could have easily been predicted by the majority of us who have the illness.
High Doses of Vitamin D Unlikely to Help MS Patients, But Daily Low Dose Good for All, UK Group Says
Conflicting evidence and opinions about the value of vitamin D supplements have contributed to a new recommendation that those of us with MS are not being advised to take them in higher doses.
The Multiple Sclerosis Trust announced that the Vitamin D working group, part of the U.K. Scientific Advisory Committee on Nutrition (SACN), has published a 300-page, comprehensive report now recommending that anyone age 4 and older take 10 μg (400 IU) of vitamin D each day to ensure musculoskeletal health. The review, “Vitamin D and Health,” was conducted to assess whether the U.K. dietary recommendations, set in 1991, were still appropriate.
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?